Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Cellular and Infection Microbiology
|
July 17, 2023
Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis
Isha Rani, Anmol Goyal, Muhammad Aaqib Shamim, et al.
Ejhaem
|
March 11, 2025
Lisocabtagene Maraleucel for Richter's Transformation-A Case Series
Courtney J Smith, Anmol Goyal, Brian R Smith, et al.
Viruses
|
June 28, 2023
Viral Loads in Skin Samples of Patients with Monkeypox Virus Infection: A Systematic Review and Meta-Analysis
Isha Rani, Prakasini Satapathy, Anmol Goyal, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
March 17, 2024
Selenium levels in colorectal cancer: A systematic review and meta-analysis of serum, plasma, and colorectal specimens
Amit Pal, Aninda Dhar, Muhammad Aaqib Shamim, et al.
Frontiers in Genetics
|
January 27, 2026
Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling
Sabyasachi Maity, Miranda Montion, Danielle Boothe, et al.
Blood Cancer Journal
|
October 13, 2023
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, et al.
Blood Advances
|
March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS
William Lee Wang, Dasom Lee, Edna Cheung, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Sushma Bharadwaj, Eric Lau, Mark P Hamilton, et al.
Blood Cancer Discovery
|
July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Blood Cancer Discovery
|
August 8, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Cellular and Infection Microbiology
|
July 17, 2023
Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis
Isha Rani, Anmol Goyal, Muhammad Aaqib Shamim, et al.
Ejhaem
|
March 11, 2025
Lisocabtagene Maraleucel for Richter's Transformation-A Case Series
Courtney J Smith, Anmol Goyal, Brian R Smith, et al.
Viruses
|
June 28, 2023
Viral Loads in Skin Samples of Patients with Monkeypox Virus Infection: A Systematic Review and Meta-Analysis
Isha Rani, Prakasini Satapathy, Anmol Goyal, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
March 17, 2024
Selenium levels in colorectal cancer: A systematic review and meta-analysis of serum, plasma, and colorectal specimens
Amit Pal, Aninda Dhar, Muhammad Aaqib Shamim, et al.
Frontiers in Genetics
|
January 27, 2026
Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling
Sabyasachi Maity, Miranda Montion, Danielle Boothe, et al.
Blood Cancer Journal
|
October 13, 2023
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, et al.
Blood Advances
|
March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS
William Lee Wang, Dasom Lee, Edna Cheung, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Sushma Bharadwaj, Eric Lau, Mark P Hamilton, et al.
Blood Cancer Discovery
|
July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Blood Cancer Discovery
|
August 8, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Page
of 3